Literature DB >> 8749162

Vertical and torsional VOR in posterior canal occlusion.

R Kanayama1, A M Bronstein, M A Gresty, G B Brookes.   

Abstract

The vertical and torsional vestibulo-ocular reflexes (VOR) were investigated in 3 patients with surgical occlusion of the posterior semicircular canal and 1 patient with singular neurectomy, for treatment of refractory paroxysmal positional vertigo. Stimuli comprised sinusoidal oscillation in the coronal ("roll") and sagittal ("pitch") plane as well as in two oblique planes intermediate between pitch in order to stimulate left anterior + right posterior (LARP) and right anterior + left posterior (RALP) canal pairs separately. One case with left side BPPV was investigated pre and post-operatively. Depression of the vertical and torsional VOR gain was seen 1 week postoperatively when the occluded canal was placed in the optimal plane for stimulation at 1 week postoperatively and subsequently gradually recovered. Recordings in other planes suggested that the contralateral posterior canal was also hypofunctioning, a finding which may explain some residual gait unsteadiness in this case. The other 3 cases who were investigated postoperatively all showed a decrease in downward VOR gain in the "on' direction of the operated canal. The data indicate the specificity of the test procedure and underline the prognostic value of comprehensive pre-operative vestibular assessment.

Entities:  

Mesh:

Year:  1995        PMID: 8749162     DOI: 10.3109/00016489509125271

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  2 in total

1.  The Tullio phenomenon: a neurologically neglected presentation.

Authors:  Diego Kaski; R Davies; L Luxon; A M Bronstein; P Rudge
Journal:  J Neurol       Date:  2011-07-09       Impact factor: 4.849

2.  Chronic Symptoms After Vestibular Neuritis and the High-Velocity Vestibulo-Ocular Reflex.

Authors:  Mitesh Patel; Qadeer Arshad; Richard Edward Roberts; Hena Ahmad; Adolfo M Bronstein
Journal:  Otol Neurotol       Date:  2016-02       Impact factor: 2.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.